arrow
R

Ryan D. Morin

Simon Fraser University
H指数:65
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activation

EBV+和EBV- BL微环境中免疫差异:活性氧生成通路和血小板活化作用

2026-03-300
OAAI
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms

蛋白质组转录组学分类和表征胰腺神经内分泌新生物

2026-02-180
OAAI
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study

基因表达谱分析揭示了两种主要的ALCL类型,具有不同的可靶向生物学特征:LLMPP研究

Blood
IF23.1
2025-11-240
PRE
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

功能基因组学和肿瘤微环境分析揭示了套细胞淋巴瘤中的预后生物学亚型

2025-11-050
OA
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

高级别B细胞淋巴瘤,非其他特指类型:一项LLMPP研究。

2025-07-210
OAAI
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis

体内CRISPR筛选揭示了KMT2D和TP53缺陷在B细胞淋巴瘤发生中的协同作用

2025-07-210
OAAI
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia
IF13.4
2025-06-300
OAAI
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma

体细胞IRF4突变和胸腺趋向性在原发性纵隔大B细胞淋巴瘤中的作用

Blood
IF23.1
2025-06-240
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study

间变性大细胞淋巴瘤的表型景观支持新的分子分类: 一项LLMPP研究

2025-03-010
PRE
Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and MYC Rearrangement- an LLMPP Study

根据EBV状态和MYC重排定义的浆细胞样淋巴瘤的生物与预后亚组——一项LLMPP研究

BLOOD
IF23.1
2024-11-050
PRE
A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy

一种基于遗传学的晚期滤泡性淋巴瘤新型分类法,可识别接受 bendamustine-rituximab 免疫化疗后的预后亚组

BLOOD
IF23.1
2024-11-050
PRE
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
2024-06-202
OAAI
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

MHG和DZsig的比较揭示了DLBCL的共同生物学和预后较差的核心重叠组

2023-10-123
OAAI